Institut de Cancérologie de l'Ouest (ICO)

Saint-Herblain 44805

0 studies enrolling now · 2 studies all time

What they study most

EGFR Exon 19 Deletion, EGFR L858R, Metastatic Prostate Cancer, Nonsquamous Non-small Cell Lung Cancer

Studies at this site

• HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy — Running, not enrolling
• A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer — Completed